Kevin Lou

6.0k total citations
10 papers, 493 citations indexed

About

Kevin Lou is a scholar working on Molecular Biology, Cell Biology and Physiology. According to data from OpenAlex, Kevin Lou has authored 10 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Physiology. Recurrent topics in Kevin Lou's work include Alzheimer's disease research and treatments (3 papers), Microtubule and mitosis dynamics (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Kevin Lou is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Microtubule and mitosis dynamics (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Kevin Lou collaborates with scholars based in United States and United Kingdom. Kevin Lou's co-authors include Kevan M. Shokat, Sarvind Tripathi, Vishnu Kumarasamy, Keelan Z. Guiley, Erik S. Knudsen, Krister J. Barkovich, Seth M. Rubin, Agnieszka K. Witkiewicz, Luke A. Gilbert and Kurt R. Brunden and has published in prestigious journals such as Nature, Science and Journal of Clinical Oncology.

In The Last Decade

Kevin Lou

10 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin Lou United States	7	264	178	96	74	71	10	493
Joachim Bischof Germany	15	587 2.2×	210 1.2×	51 0.5×	128 1.7×	61 0.9×	33	826
Cynthia M. Rominger United States	10	522 2.0×	247 1.4×	71 0.7×	30 0.4×	46 0.6×	11	748
Kia Strömberg Sweden	9	323 1.2×	96 0.5×	45 0.5×	35 0.5×	113 1.6×	10	491
Viswanath Das Czechia	14	257 1.0×	91 0.5×	22 0.2×	64 0.9×	99 1.4×	38	510
Annie Olivier France	10	262 1.0×	153 0.9×	46 0.5×	68 0.9×	24 0.3×	12	492
Linda Sleire Norway	10	355 1.3×	161 0.9×	118 1.2×	37 0.5×	42 0.6×	13	689
Anice Moumen France	13	333 1.3×	79 0.4×	30 0.3×	108 1.5×	69 1.0×	15	680
Mayumi Fujita Japan	17	406 1.5×	166 0.9×	96 1.0×	68 0.9×	103 1.5×	29	711
Wade H. Aaron United States	8	178 0.7×	109 0.6×	29 0.3×	60 0.8×	70 1.0×	18	404
Francesca De Giorgi Italy	9	481 1.8×	95 0.5×	48 0.5×	45 0.6×	26 0.4×	9	621

Countries citing papers authored by Kevin Lou

Since Specialization

Citations

This map shows the geographic impact of Kevin Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Lou more than expected).

Fields of papers citing papers by Kevin Lou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Lou. The network helps show where Kevin Lou may publish in the future.

Co-authorship network of co-authors of Kevin Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Lou. A scholar is included among the top collaborators of Kevin Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Lou. Kevin Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Zhang, Ziyang, et al.. (2022). Brain-restricted mTOR inhibition with binary pharmacology. Nature. 609(7928). 822–828. 52 indexed citations

Lou, Kevin, Tangpo Yang, Ziyang Zhang, et al.. (2022). IFITM proteins assist cellular uptake of diverse linked chemotypes. Science. 378(6624). 1097–1104. 24 indexed citations

Ly, Ina, Alona Muzikansky, Kevin Lou, et al.. (2022). Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma.. Journal of Clinical Oncology. 40(16_suppl). 2030–2030. 1 indexed citations

Guiley, Keelan Z., Kevin Lou, Krister J. Barkovich, et al.. (2019). p27 allosterically activates cyclin-dependent kinase 4 and antagonizes palbociclib inhibition. Science. 366(6471). 154 indexed citations

Lou, Kevin, Veronica Steri, Alex Y. Ge, et al.. (2019). KRAS ^G12C inhibition produces a driver-limited state revealing collateral dependencies. Science Signaling. 12(583). 116 indexed citations

Lou, Kevin, Luke A. Gilbert, & Kevan M. Shokat. (2019). A Bounty of New Challenging Targets in Oncology for Chemical Discovery. Biochemistry. 58(31). 3328–3330. 4 indexed citations

Makani, Vishruti, Bin Zhang, Yuemang Yao, et al.. (2016). Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy. Acta Neuropathologica Communications. 4(1). 106–106. 44 indexed citations

Lou, Kevin, Yuemang Yao, Adam T. Hoye, et al.. (2014). Brain-Penetrant, Orally Bioavailable Microtubule-Stabilizing Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s Disease and Related Tauopathies. Journal of Medicinal Chemistry. 57(14). 6116–6127. 73 indexed citations

Ballatore, Carlo, Alex Crowe, Francesco Piscitelli, et al.. (2012). Aminothienopyridazine inhibitors of tau aggregation: Evaluation of structure–activity relationship leads to selection of candidates with desirable in vivo properties. Bioorganic & Medicinal Chemistry. 20(14). 4451–4461. 23 indexed citations

10.

Gruber, James V., et al.. (2007). Can a topical scalp treatment reduce hair bulb extraction?. PubMed. 58(4). 369–74. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact